CD45RA, Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD45RA, Mouse antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD45RA, Mouse |
| Clone | 14.8 |
| Host Species | Rat |
| Reactive Species | mouse |
| Isotype | IgG2bκ |
| Format | fluorescein (FITC) conjugate |
| Size | 9 µg in 300 µL |
| Concentration | 1:10 |
| Applications | Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD45RA Antibody, anti-mouse, FITC. The monoclonal antibody 14.8 recognizes the exon A-dependent epitope CD45RA, one of eight isoforms of the transmembrane glycoprotein CD45, which is a member of the PTP (Protein Tyrosine Phosphatase) family. CD45RA is expressed highly on B cells, weakly on CD8+ T cells and nearly on all B-lineage cells but it is not detectable on hematopoietic stem cells or myeloid progenitors. |
| Immunogen | n/a |
| Other Names | Ptprc, loc, Lyt-4, CD45, L-CA, Ly-5 |
| Gene, Accession # | Gene ID: 19264 |
| Catalog # | 130-102-954 |
| Price | $24 |
| Order / More Info | CD45RA, Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Hathcock, K. S. et al. (1992) Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell populations. J Immunol 148: 19-28. | Inoue, T. et al. (1993) Distinction of mouse CD8+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine. J Immunol 150: 2121-2128. | Trowbridge, I. S. et al. (1991) CD45: a leukocyte-specific member of the protein tyrosine phosphatase family. J Immunol 1095 (1): 46-56. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies